JPH034791A - Stabilization of enzyme - Google Patents
Stabilization of enzymeInfo
- Publication number
- JPH034791A JPH034791A JP13766689A JP13766689A JPH034791A JP H034791 A JPH034791 A JP H034791A JP 13766689 A JP13766689 A JP 13766689A JP 13766689 A JP13766689 A JP 13766689A JP H034791 A JPH034791 A JP H034791A
- Authority
- JP
- Japan
- Prior art keywords
- enzyme
- aqueous solution
- stabilizing
- hyaluronic acid
- enzymes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 26
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 26
- 230000006641 stabilisation Effects 0.000 title description 3
- 238000011105 stabilization Methods 0.000 title description 3
- 108091005804 Peptidases Proteins 0.000 claims abstract description 18
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 12
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 12
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 12
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 11
- 239000005017 polysaccharide Substances 0.000 claims abstract description 11
- 150000004804 polysaccharides Chemical class 0.000 claims abstract description 11
- 239000007864 aqueous solution Substances 0.000 claims abstract description 10
- 150000003839 salts Chemical class 0.000 claims abstract description 5
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 4
- 229920000615 alginic acid Polymers 0.000 claims abstract description 4
- 239000000783 alginic acid Substances 0.000 claims abstract description 4
- 229960001126 alginic acid Drugs 0.000 claims abstract description 4
- 150000004781 alginic acids Chemical class 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 21
- 230000000087 stabilizing effect Effects 0.000 claims description 14
- 102000035195 Peptidases Human genes 0.000 claims description 12
- 229940088598 enzyme Drugs 0.000 abstract description 22
- 239000004365 Protease Substances 0.000 abstract description 7
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract description 6
- 108090000317 Chymotrypsin Proteins 0.000 abstract description 2
- 108090000284 Pepsin A Proteins 0.000 abstract description 2
- 102000057297 Pepsin A Human genes 0.000 abstract description 2
- 108090000631 Trypsin Proteins 0.000 abstract description 2
- 102000004142 Trypsin Human genes 0.000 abstract description 2
- 229960002376 chymotrypsin Drugs 0.000 abstract description 2
- 229940111202 pepsin Drugs 0.000 abstract description 2
- 239000012588 trypsin Substances 0.000 abstract description 2
- 229960001322 trypsin Drugs 0.000 abstract description 2
- 108010019160 Pancreatin Proteins 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 229940055695 pancreatin Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 18
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000012085 test solution Substances 0.000 description 5
- 239000005018 casein Substances 0.000 description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 4
- 235000021240 caseins Nutrition 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 235000019419 proteases Nutrition 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 239000010200 folin Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- XRFXFAVKXJREHL-UHFFFAOYSA-N arsinine Chemical compound [As]1=CC=CC=C1 XRFXFAVKXJREHL-UHFFFAOYSA-N 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 108010003855 mesentericopeptidase Proteins 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229920003087 methylethyl cellulose Polymers 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000009991 scouring Methods 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Description
【発明の詳細な説明】 (産業上の利用分野) 本発明はタンパク質分解酵素の安定化方法に関する。[Detailed description of the invention] (Industrial application field) The present invention relates to a method for stabilizing proteolytic enzymes.
(従来の技術分野)
酵素は、常温で、特異的、選択的な反応を行う触媒とし
て、多くの分野で利用が進んでいる。タンパク質分解酵
素も、医薬、洗剤、化粧品や、絹の精練などに有効に利
用されている。しかし、こうした生体触媒は熱やpH変
化などに対する安定性が低く、その応用が制限される欠
点がある。(Conventional Technical Field) Enzymes are being increasingly used in many fields as catalysts that carry out specific and selective reactions at room temperature. Proteolytic enzymes are also effectively used in medicines, detergents, cosmetics, and silk scouring. However, these biocatalysts have low stability against heat and pH changes, which limits their applications.
特に酵素を含有する形態が水を含む系であったり、水溶
液の場合、保存中にも速やかに活性が低下する問題点が
あり、実際には、皿々の安定化剤を添加したり、冷蔵保
存する等の対策がとられている。In particular, if the form containing the enzyme is water-containing or an aqueous solution, there is a problem that the activity quickly decreases during storage. Measures are being taken to:
酵素の失活は、一般には熱運動による構造変化に基づく
、変性失活と考えられるが、タンパク質分解酵素の場合
は、更に酵素相互の分解(自己消化)による失活も起こ
る。Enzyme inactivation is generally considered to be denaturation inactivation based on structural changes due to thermal movement, but in the case of proteolytic enzymes, inactivation also occurs due to mutual decomposition of the enzymes (autolysis).
このような酵素の失活要因を考慮し、タンパク質分解酵
素の安定化に関し既に多数の提案がなされている。例え
ば、タンパク質分解酵素の水溶液に、カゼイン、ゼラチ
ンなどを添加する方法(特公昭4l−182号公報)、
可溶性高分子に酵素を共有結合させ、その水溶液に更に
アルブミン、ゼラチンなどのタンパク質を添加する方法
(特開昭557−122796号公報)、又酵素を配合
した液体洗剤にカルシウムイオン、ギ酸ナトリウム、ア
ルコールなどを添加する方法(特公昭58−11198
号公報)、ジカルボン酸及び還元性無機塩類を添加する
方法(特公昭59−217799号公報)などが知られ
ている。Many proposals have already been made regarding the stabilization of proteolytic enzymes in consideration of such enzyme inactivation factors. For example, a method of adding casein, gelatin, etc. to an aqueous solution of a proteolytic enzyme (Japanese Patent Publication No. 41-182);
A method in which an enzyme is covalently bonded to a soluble polymer and further proteins such as albumin and gelatin are added to the aqueous solution (Japanese Patent Application Laid-Open No. 122796/1983), and a method in which calcium ions, sodium formate, and alcohol are added to a liquid detergent containing an enzyme. Method of adding etc. (Special Publication No. 58-11198
(Japanese Patent Publication No. 59-217799) and the like are known.
しかるに、上記既存の方法は目的によっては、その配合
が制限されたり、タンパク質の油類によっては、その分
解による異臭の発生が問題となる。However, depending on the purpose, the above-mentioned existing methods have limitations on their formulations, and depending on the protein oil, there is a problem in that the decomposition of the protein oil may generate off-flavors.
又、その効果の点に於いても一応成る程度の有効性は認
められるが、未だ満足すべき効果が得られていない。特
に高温条件下での安定化効果は低く、流通、保存過程で
高温雰囲気下に曝らされると大幅に活性が損われるとと
がある。Also, in terms of its effects, it has been recognized that it is effective to a certain degree, but a satisfactory effect has not yet been obtained. In particular, the stabilizing effect under high temperature conditions is low, and the activity is said to be significantly impaired when exposed to high temperature atmosphere during distribution and storage processes.
(発明が解決しようとする課題)
本発明者らは、上述の問題点を解決すべ(、鋭意研究を
行なった結果、本発明を完成したものであってその目的
とするところは、安定性、特に高温安定性が著しく向上
すると共に、その適用範囲が広い酵素の安定化法を提供
するにある。(Problems to be Solved by the Invention) The present inventors have completed the present invention as a result of intensive research to solve the above-mentioned problems. In particular, it is an object of the present invention to provide a method for stabilizing enzymes that significantly improves high-temperature stability and has a wide range of applications.
(課題を解決するための手段)
上述の目的は、タンパク質分解酵素の水性溶液に多糖類
を0.06%以上添加することを特徴とする酵素の安定
化方法により達成される。(Means for Solving the Problem) The above object is achieved by a method for stabilizing an enzyme, which is characterized by adding 0.06% or more of polysaccharide to an aqueous solution of a proteolytic enzyme.
本発明に用いられるタンパク質分解酵素は特に限定され
ないが、動物起源のペプシン、キモトリプシン、トリプ
シン、バンクレアチン等、植物起源のパパイン、微生物
起源のアスペルギス属、リゾプス属、バチルス属の産生
ずるタンパク質分解酵素等が挙げられる。The proteolytic enzymes used in the present invention are not particularly limited, but include animal-derived pepsin, chymotrypsin, trypsin, bancreatin, etc., plant-derived papain, microbial-derived proteolytic enzymes produced by Aspergis, Rhizopus, and Bacillus, etc. can be mentioned.
本発明の多糖類としては、アラビアガム、グアーガム、
ザンタンガム、ローカストビーンガム。The polysaccharides of the present invention include gum arabic, guar gum,
Xanthan gum, locust bean gum.
デンプン、デキストラン、プルラン、アルギン酸。Starch, dextran, pullulan, alginic acid.
ヒアルロン酸、カラギーナン、ペクチン、キトサンなど
の天然多糖類、及びそれらの塩や誘導体、又、カルボキ
シメチルセルロース、メチルセルロース、エチルセルロ
ース、ヒドロキシプロピルセルロースなどのセルロース
誘導体、及びそれらの塩などが挙げられ、水可溶のもの
であれば用いることができるが、その効果の大きさ、使
い易さなどからヒアルロン酸、アルギン酸及びそれらの
塩が好ましい。用いる多糖類の濃度は多糖類の種類、分
子量により異なるが、高濃度になる程、その効果も大き
くなる傾向があり、O,OS重量%以上であることが必
要である。上限は特に限定されないが、過度に添加して
も効果が飽和することや粘性などの物性、溶解度等を考
慮すると好ましくは0.05〜205〜20重量%まし
くは0.5〜10重量%の範囲で用いられる。Natural polysaccharides such as hyaluronic acid, carrageenan, pectin, and chitosan, salts and derivatives thereof, cellulose derivatives such as carboxymethyl cellulose, methyl cellulose, ethyl cellulose, and hydroxypropyl cellulose, and salts thereof, etc., are water-soluble. Although any substance can be used, hyaluronic acid, alginic acid, and their salts are preferred from the viewpoint of their effectiveness and ease of use. The concentration of the polysaccharide used varies depending on the type and molecular weight of the polysaccharide, but the higher the concentration, the greater the effect tends to be, and it is necessary to be at least O,OS weight %. Although the upper limit is not particularly limited, it is preferably 0.05 to 205 to 20% by weight or 0.5 to 10% by weight, considering that the effect will be saturated even if added excessively, physical properties such as viscosity, solubility, etc. Used within the range of
(発明の効果)
本発明の方法によると、水性溶液中の酵素は安定化され
るが、その程度は多糖類の可類、濃度の他、酵素の種類
、濃度にも依存する。更に、本発明の方法では、30℃
以上の高温領域で、その安定化能が顕著に高いことが特
長的であり、条件によっては、50℃で24時間保存し
ても、殆んどその活性は失われない。(Effects of the Invention) According to the method of the present invention, enzymes in an aqueous solution are stabilized, but the degree of stabilization depends on the type and concentration of the enzyme as well as the type and concentration of the polysaccharide. Furthermore, in the method of the present invention, 30°C
It is characterized by its remarkably high stabilizing ability in the above-mentioned high temperature range, and under certain conditions, its activity is hardly lost even when stored at 50°C for 24 hours.
本発明の方法は、化学修飾したg累や、不溶性担体に結
合した酵素に適用することもできる。更に、他の安定化
剤と共に添加することもできるばかりでなく、各柵界面
活性剤水溶液系に添加してもその効果を示すことが大き
な特長である。The method of the invention can also be applied to chemically modified molecules or enzymes bound to insoluble carriers. Furthermore, a major feature is that not only can it be added together with other stabilizers, but it also exhibits its effect even when added to each fence surfactant aqueous solution system.
本発明の方法は、上述した如く、水系媒体中の酵素の安
定性、特に高温安定性を大きく向上させ、その適用範囲
が広く、又、安全な方法であることから、化粧品、薬品
、洗剤などの化成品に好適に応用できるばかりでなく、
それらの商品が流通、保存の間に高温にさらされること
に起因するトラブルを避けることができる。As mentioned above, the method of the present invention greatly improves the stability of enzymes in aqueous media, especially high temperature stability, has a wide range of applications, and is a safe method, so it can be used in cosmetics, medicines, detergents, etc. Not only can it be suitably applied to chemical products, but also
Trouble caused by exposure of these products to high temperatures during distribution and storage can be avoided.
又、こうした蛋白分解酵素を食品などの製造、処理プロ
セスに応用する場合や、合成反応に利用する場合にも、
有用な方法である。In addition, when applying these proteolytic enzymes to food manufacturing and processing processes, and when using them for synthetic reactions,
This is a useful method.
以下、本発明を実施例により具体的に説明する。Hereinafter, the present invention will be specifically explained with reference to Examples.
なお、実施例における活性測定並びに試桑及び溶液の調
製は下記により行った。In addition, the activity measurement and preparation of test mulberry and solution in Examples were performed as follows.
プロテアーゼ活性は、アンソン氏改良法に基づき、以下
の方法で測定した。Protease activity was measured by the following method based on Anson's modified method.
カゼイン溶液smlを試験管(18X180mox)
に入れ、sO±0.5℃で10分間放置した後、試料
溶液i ml を正確に量って加え、直ちに振り混ぜ色
。この液を50±0.5℃で正確に1゜分間放置し、ト
リクロル酢酸試液15m1 を加えて振り混ぜ、再び5
0±o、 s ’cで50分間放置した後、濾紙(陽1
31、φsem)で纏過せ乙。濾液2 rne を正確
に量り、O,56M炭酸ナトリウム試液5ml及び、フ
ォリン試液1.Qmll を加え、40℃で30分間放
置した後、粧原基一般試験法、吸光度測定法によりe
e o nmにおける吸光度At を測定ぢbo
空試験として別に試験溶液1 ml を正確に量り、ト
リクロル酢酸5.0 ml を加えて振り混ぜb0更に
カゼイン溶液6rr11 を加えて振り混ぜ、50±0
.5℃で30分間放置し、以下同様に操作して、吸光度
ムbを測定電ト。Casein solution sml in test tube (18X180mox)
After leaving it for 10 minutes at sO ± 0.5°C, accurately measure and add 1 ml of the sample solution, and immediately shake and stir. This solution was left at 50 ± 0.5°C for exactly 1°, then 15ml of trichloroacetic acid test solution was added, shaken, and heated again at 50°C.
After leaving it for 50 minutes at 0±o, s 'c,
31, φsem). Accurately measure 2 rne of filtrate, add 5 ml of O, 56M sodium carbonate reagent and 1.0 ml of Folin reagent. After adding Qmll and leaving it for 30 minutes at 40°C, e
Measure the absorbance At at e o nm. Separately, as a blank test, accurately measure 1 ml of the test solution, add 5.0 ml of trichloroacetic acid, and shake. b0 Furthermore, add 6 ml of casein solution and shake to 50 ± 0.
.. Leave it at 5°C for 30 minutes, then repeat the same procedure to measure the absorbance.
プロテアーゼ力価は、次式により求めboなお、この条
件下で1分間に1μfのチロシン量に相当する非蛋白性
のフォリン試液呈色物質の増加をもたらす酵素量を1プ
ロテア一ゼ活性単位と隻り0プロテアーゼ力価(単位/
f)=(At−ムb)X415.1SXNN:試料の希
釈倍数(If当り)
〔試薬及び試液〕
1)カゼイン溶液
乳性カゼイン約1gを正確に量り、105℃で2時間乾
燥し、その減量を測定しさ。その乾燥物1.2Ofに対
応する乳性カゼインを正確に冷却した後1N水酸化ナト
リウム試液でpH8,0に調製した後、水を加えて20
0m1と°15&。The protease titer is calculated using the following formula. Under these conditions, the amount of enzyme that causes an increase in the non-protein folin reagent colored substance equivalent to the amount of tyrosine of 1 μf per minute is defined as 1 protease activity unit. 0 protease titer (units/
f) = (At-mu b) Measure the quality. After accurately cooling the milk casein corresponding to 1.2Of the dried product, adjusting the pH to 8.0 with 1N sodium hydroxide test solution, and adding water to 20
0m1 and °15&.
2)トリクロル酢酸試液
トリクロル酢酸1.8gおよび無水酢酸ナトリウム1,
8fに6N酢酸rt、smIおよび水を加えrlQOm
gとしb0
3)0.68M炭酸ナトリウム試液
無水炭酸ナトリウム68.5 Fに水を加えて溶かし、
1000 ml とルb0
4)フォリン試液
フェノール試薬(和光紬薬製)を2倍希釈して用いも。2) Trichloroacetic acid test solution 1.8 g of trichloroacetic acid and 1.8 g of anhydrous sodium acetate,
Add 6N acetic acid rt, smI and water to 8f and rlQOm
g and b0 3) 0.68M sodium carbonate test solution Add water to anhydrous sodium carbonate 68.5 F and dissolve.
4) Folin reagent phenol reagent (manufactured by Wako Tsumugi Pharmaceutical Co., Ltd.) may be diluted 2 times and used.
実施例1
バチルス・リケニホルミスの産生ずるタンパク質分解酵
素エスペラーゼ(ノボ社製)を精製し、50℃における
安定性に対する添加物効果を検討した結果を第1表に示
す。Example 1 The proteolytic enzyme esperase (manufactured by Novo) produced by Bacillus licheniformis was purified and the effect of additives on stability at 50°C was investigated. The results are shown in Table 1.
第1表
同表より明らかな様に、一般に安定化剤として用いられ
る単糖、二糖類にも若干の安定化傾向が認められるが、
多糖類特にアルギン酸ナトリウム、ヒアルロン酸の安定
化効果は著しく高いことがわかる。As is clear from Table 1, monosaccharides and disaccharides commonly used as stabilizers also have a slight stabilizing tendency.
It can be seen that the stabilizing effects of polysaccharides, particularly sodium alginate and hyaluronic acid, are extremely high.
実施例2
バチルス属菌由来のタンパク質分解酵素ビオブラーゼコ
ンク(長瀬生化学工業■!!りを精製し、実験例1と同
様の検討を行なった結果を第2表に示す。Example 2 The proteolytic enzyme biobrase conc. (Nagase Seikagaku Kogyo ■!!) derived from Bacillus was purified, and the same study as in Experimental Example 1 was conducted. The results are shown in Table 2.
第2表 但し 添加物濃度 酵素 熱処理 pH 1% 40単位1me 50’C目 8.0 hr、 但し 添加物濃度 1% ひ 素 40単位1ml 熱処理 60℃ 15hr。Table 2 however Additive concentration enzyme Heat treatment pH 1% 40 units 1me 50'C 8.0 hr, however Additive concentration 1% Arsenine 40 units 1ml Heat treatment 60℃ 15hr.
p H8,0
同表から明らかな様に本酵素についても多糖類、特にア
ルギン酸ナトリウム、ヒアルロン酸は、著しい安定化効
果が認められた。pH 8.0 As is clear from the same table, polysaccharides, especially sodium alginate and hyaluronic acid, had a significant stabilizing effect on this enzyme.
実施例3
実施例1と同様にして調製した酵素を各種溶液に溶解し
、これらにヒアルロン酸0.5重量%添加した場合の安
定性に対する影響を50℃で検討した。この結果を第3
表に示す。Example 3 Enzymes prepared in the same manner as in Example 1 were dissolved in various solutions, and the effect on stability when 0.5% by weight of hyaluronic acid was added thereto was investigated at 50°C. This result is the third
Shown in the table.
第3表
同表より、他の安定化剤や界面活性剤中でも、添加効果
が発現することがわかる。From Table 3, it can be seen that the effect of addition is expressed even in other stabilizers and surfactants.
実施例4
実施例1と同様にして調製した酵素の37℃安定性をヒ
アルロン酸1%添加、無添加の系について検討した。Example 4 The 37°C stability of an enzyme prepared in the same manner as in Example 1 was investigated in systems with and without the addition of 1% hyaluronic acid.
10日後の活性残存率は、無添加の場合85%であった
が、1.0%ヒアルロン酸を添加すると82%となった
。The activity residual rate after 10 days was 85% without the addition, but it became 82% with the addition of 1.0% hyaluronic acid.
実施例5
酵素濃度及び添加するヒアルロン酸の濃度と50℃安定
性の関係について検討した結果を笛4表に示す。Example 5 Table 4 shows the results of examining the relationship between the enzyme concentration, the concentration of hyaluronic acid added, and the 50°C stability.
第4表 を検討した結果を第5表に示す。Table 4 The results of the study are shown in Table 5.
第6表
同表から特にヒアルロン酸濃度0.06%以上で大きな
安定化効果が認められ、濃度の増大とともに安定化効果
も増大し、また酵素濃度が低いほど安定化効果は大きい
ことがわかる。From Table 6, it can be seen that a particularly large stabilizing effect is observed at a hyaluronic acid concentration of 0.06% or higher, and that the stabilizing effect increases as the concentration increases, and that the lower the enzyme concentration is, the greater the stabilizing effect is.
実施例6
実施例5と同様にして、31℃における安定性50℃の
場合はど大きな効果ではないが、ヒアルロン酸添加によ
る安定化は効果が明らかに認められた。Example 6 In the same manner as in Example 5, stability at 31° C. Although the effect was not very great at 50° C., the stabilizing effect by adding hyaluronic acid was clearly observed.
Claims (2)
5重量%以上添加することを特徴とする酵素の安定化方
法。(1) Add 0.0% polysaccharide to the aqueous solution of proteolytic enzyme
A method for stabilizing an enzyme, characterized by adding 5% by weight or more.
び/またはヒアルロン酸あるいはその塩を添加すること
を特徴とする酵素の安定化方法。(2) A method for stabilizing an enzyme, which comprises adding alginic acid and/or hyaluronic acid or a salt thereof to an aqueous solution of a proteolytic enzyme.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13766689A JPH034791A (en) | 1989-05-30 | 1989-05-30 | Stabilization of enzyme |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13766689A JPH034791A (en) | 1989-05-30 | 1989-05-30 | Stabilization of enzyme |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH034791A true JPH034791A (en) | 1991-01-10 |
Family
ID=15203976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13766689A Pending JPH034791A (en) | 1989-05-30 | 1989-05-30 | Stabilization of enzyme |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH034791A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995025707A1 (en) * | 1994-03-22 | 1995-09-28 | Biotal Ltd. | Enhanced biological degradation of organic waste systems |
US5527487A (en) * | 1991-11-27 | 1996-06-18 | Novo Nordisk A/S | Enzymatic detergent composition and method for enzyme stabilization |
WO2006020208A3 (en) * | 2004-07-26 | 2006-06-01 | Merz Pharma Gmbh & Co Kgaa | Therapeutic composition whit a botulinum neurotoxin |
JP2007519408A (en) * | 2004-01-30 | 2007-07-19 | ビーエーエスエフ アクチェンゲゼルシャフト | Stabilized enzyme preparation |
US8220921B2 (en) | 2008-08-29 | 2012-07-17 | Takata Corporation | Inkjet dyeing apparatus |
WO2016060224A1 (en) * | 2014-10-17 | 2016-04-21 | 合同酒精株式会社 | Lactase solution and milk using same |
EP3068861B1 (en) | 2013-11-11 | 2020-03-18 | Ecolab USA Inc. | Multiuse, enzymatic detergent and methods of stabilizing a use solution |
RU2744457C1 (en) * | 2020-07-28 | 2021-03-09 | федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет" (ФГБОУ ВО "ВГУ") | Method for obtaining an immobilized enzyme product based on ficin, hyaluronic acid and polysaccharides modified with vinyl monomers |
RU2750377C1 (en) * | 2020-07-27 | 2021-06-28 | федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет" (ФГБОУ ВО "ВГУ") | Method for producing immobilized enzyme preparation based on bromelain, hyaluronic acid and polysaccharides modified with vinyl monomers |
WO2022071417A1 (en) * | 2020-09-29 | 2022-04-07 | キッコーマン株式会社 | Method for improving stability of composition containing flavin-dependent lactate dehydrogenase |
-
1989
- 1989-05-30 JP JP13766689A patent/JPH034791A/en active Pending
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5527487A (en) * | 1991-11-27 | 1996-06-18 | Novo Nordisk A/S | Enzymatic detergent composition and method for enzyme stabilization |
WO1995025707A1 (en) * | 1994-03-22 | 1995-09-28 | Biotal Ltd. | Enhanced biological degradation of organic waste systems |
JP2007519408A (en) * | 2004-01-30 | 2007-07-19 | ビーエーエスエフ アクチェンゲゼルシャフト | Stabilized enzyme preparation |
US9220783B2 (en) | 2004-07-26 | 2015-12-29 | Merz Pharma Gmbh & Co. Kgaa | Therapeutic composition with a botulinum neurotoxin |
US10105421B2 (en) | 2004-07-26 | 2018-10-23 | Merz Pharma Gmbh & Co. Kgaa | Therapeutic composition with a botulinum neurotoxin |
US7879341B2 (en) | 2004-07-26 | 2011-02-01 | Merz Pharma Gmbh & Co. Kgaa | Therapeutic composition with a botulinum neurotoxin |
EP2266599A3 (en) * | 2004-07-26 | 2012-11-21 | Merz Pharma GmbH & Co. KGaA | Therapeutic composition with a botulinum neurotoxin |
US8372645B2 (en) | 2004-07-26 | 2013-02-12 | Merz Pharma Gmbh & Co. Kgaa | Therapeutic composition with a botulinum neurotoxin |
US9050367B2 (en) | 2004-07-26 | 2015-06-09 | Merz Pharma Gmbh & Co. Kgaa | Therapeutic composition with a botulinum neurotoxin |
WO2006020208A3 (en) * | 2004-07-26 | 2006-06-01 | Merz Pharma Gmbh & Co Kgaa | Therapeutic composition whit a botulinum neurotoxin |
EA011652B1 (en) * | 2004-07-26 | 2009-04-28 | Мерц Фарма Гмбх Унд Ко. Кгаа | Therapeutic composition whit a botulinum neurotoxin |
US8220921B2 (en) | 2008-08-29 | 2012-07-17 | Takata Corporation | Inkjet dyeing apparatus |
EP3068861B1 (en) | 2013-11-11 | 2020-03-18 | Ecolab USA Inc. | Multiuse, enzymatic detergent and methods of stabilizing a use solution |
US10995303B2 (en) | 2013-11-11 | 2021-05-04 | Ecolab Usa Inc. | Multiuse, enzymatic detergent and methods of stabilizing a use solution |
US11905497B2 (en) | 2013-11-11 | 2024-02-20 | Ecolab Usa Inc. | Multiuse, enzymatic detergent and methods of stabilizing a use solution |
JP2016163597A (en) * | 2014-10-17 | 2016-09-08 | 合同酒精株式会社 | Lactase solution and milk using the same |
JP5959132B1 (en) * | 2014-10-17 | 2016-08-02 | 合同酒精株式会社 | Lactase solution and milk using the same |
EP3208332B1 (en) | 2014-10-17 | 2020-03-04 | Godo Shusei Co., Ltd. | Lactase solution and milk using same |
WO2016060224A1 (en) * | 2014-10-17 | 2016-04-21 | 合同酒精株式会社 | Lactase solution and milk using same |
RU2750377C1 (en) * | 2020-07-27 | 2021-06-28 | федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет" (ФГБОУ ВО "ВГУ") | Method for producing immobilized enzyme preparation based on bromelain, hyaluronic acid and polysaccharides modified with vinyl monomers |
RU2744457C1 (en) * | 2020-07-28 | 2021-03-09 | федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет" (ФГБОУ ВО "ВГУ") | Method for obtaining an immobilized enzyme product based on ficin, hyaluronic acid and polysaccharides modified with vinyl monomers |
WO2022071417A1 (en) * | 2020-09-29 | 2022-04-07 | キッコーマン株式会社 | Method for improving stability of composition containing flavin-dependent lactate dehydrogenase |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0722492B1 (en) | Stabilisation of proteins in solution | |
JPH07502900A (en) | Method for sustaining the activity of polyethylene glycol-denatured protease | |
JPS63252543A (en) | Water-soluble microcapsule | |
JPH034791A (en) | Stabilization of enzyme | |
AU2005225085A1 (en) | Stable thrombin composition | |
WO1991014773A2 (en) | Enzyme stabilisation | |
JPH02219571A (en) | Modified protease and production thereof | |
JPH06116300A (en) | Keratin fragment and its production | |
JPH034790A (en) | Stabilization of enzyme | |
Daba et al. | Chemical modification of wheat β-amylase by trinitrobenzenesulfonic acid, methoxypolyethylene glycol, and glutaraldehyde to improve its thermal stability and activity | |
JP2007517939A (en) | A simple method for recovering chitosan from its acidic solution | |
JP2919912B2 (en) | Modified protease and method for producing the same | |
JPS61257906A (en) | Packing cosmetic | |
US20020061568A1 (en) | Method for activating denatured protein | |
JP2002233362A (en) | Method for stabilizing laccase activity and stabilized laccase composition | |
RU2795425C1 (en) | Method for obtaining hybrid preparation of papain and carboxymethylcellulose in the form of a dense solution | |
JPH07265075A (en) | Stable modified protease composition and stable enzyme-containing aqueous solution containing the same composition | |
RU2788454C1 (en) | Method for producing hybrid preparation of bromelain and carboxymethylcellulose in the form of a dense solution | |
US4439522A (en) | Proteolytic enzyme composition | |
RU2788455C1 (en) | Method for obtaining a composite preparation of papain and sodium alginate in the form of a thick solution | |
RU2792783C1 (en) | Method for obtaining ficin and chitosan acetate hybrid preparation in the form of a dense solution | |
RU2771183C1 (en) | Method for producing ficin preparation in gel based on carboxymethylcellulose | |
JPH0466087A (en) | Method for stabilizing ascorbate oxidase and stabilized composition of the same enzyme | |
JP2902747B2 (en) | Method for producing modified protease | |
JPH02219572A (en) | Modified protease and production thereof |